Mipomersen, an apolipoprotein B synthesis inhibitor, for lowering of LDL cholesterol concentrations in patients with homozygous familial hypercholesterolaemia: a randomised, double-blind, placebo-controlled trial
published in: The Lancet
date of publication: 2010-03-01
language: English
main subject: hypercholesterolemia, placebo, mipomersen parent acid, homozygosity
Cites articles 25
- 2008-02-19
- 2000-01-01
Date
Title
Article - wd:Q43130496